These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 38657353

  • 1. Candida albicans cDNA library screening reveals novel potential diagnostic targets for invasive candidiasis.
    Bregón-Villahoz M, Menéndez-Manjón P, Carrano G, Díez-Villalba A, Arrieta-Aguirre I, Fernandez-de-Larrinoa I, Moragues MD.
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116311. PubMed ID: 38657353
    [Abstract] [Full Text] [Related]

  • 2. Anti-Candida Antibodies of Patients with Invasive Candidiasis Inhibit Growth, Alter Cell Wall Structure, and Kill Candida albicans In Vitro.
    Carrano G, Arrieta-Aguirre I, Díez A, Bregón-Villahoz M, Fernandez-de-Larrinoa I, Moragues MD.
    Mycopathologia; 2024 Feb 07; 189(1):16. PubMed ID: 38324097
    [Abstract] [Full Text] [Related]

  • 3. Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.
    Parra-Sánchez M, Zakariya-Yousef Breval I, Castro Méndez C, García-Rey S, Loza Vazquez A, Úbeda Iglesias A, Macías Guerrero D, Romero Mejías A, León Gil C, Martín-Mazuelos E, CAVA Trem Study Group.
    Mycopathologia; 2017 Aug 07; 182(7-8):645-652. PubMed ID: 28378240
    [Abstract] [Full Text] [Related]

  • 4. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
    Pini P, Colombari B, Marchi E, Castagnoli A, Venturelli C, Sarti M, Blasi E.
    Diagn Microbiol Infect Dis; 2019 Jan 07; 93(1):39-43. PubMed ID: 30098849
    [No Abstract] [Full Text] [Related]

  • 5. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Díez A, Carrano G, Bregón-Villahoz M, Cuétara MS, García-Ruiz JC, Fernandez-de-Larrinoa I, Moragues MD.
    Diagn Microbiol Infect Dis; 2021 Nov 07; 101(3):115509. PubMed ID: 34384954
    [Abstract] [Full Text] [Related]

  • 6. Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients.
    Pitarch A, Nombela C, Gil C.
    J Proteome Res; 2014 Nov 07; 13(11):5165-84. PubMed ID: 25377742
    [Abstract] [Full Text] [Related]

  • 7. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
    Pemán J, Zaragoza R, Quindós G, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J, study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients.
    BMC Infect Dis; 2011 Mar 09; 11():60. PubMed ID: 21388550
    [Abstract] [Full Text] [Related]

  • 8. Role of Candida Albicans Germ Tube Antibody in Diagnosis of Invasive Candidiasis in End Stage Liver Disease Patients.
    Azzazy EA, El-Gammal NE, Metwally WS, Attia MH.
    Egypt J Immunol; 2018 Jan 09; 25(1):161-170. PubMed ID: 30243008
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis.
    Wei S, Wu T, Wu Y, Ming D, Zhu X.
    Diagn Microbiol Infect Dis; 2019 Apr 09; 93(4):339-345. PubMed ID: 30552034
    [Abstract] [Full Text] [Related]

  • 10. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E, Loza A, Castro C, Macías D, Zakariya I, Saavedra P, Ruiz-Santana S, Marín E, León C.
    Intensive Care Med; 2015 Aug 09; 41(8):1424-32. PubMed ID: 26134359
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.
    Trovato L, Astuto M, Castiglione G, Scalia G, Oliveri S.
    J Microbiol Immunol Infect; 2020 Oct 09; 53(5):778-784. PubMed ID: 30902614
    [Abstract] [Full Text] [Related]

  • 12. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
    León C, Ruiz-Santana S, Saavedra P, Castro C, Loza A, Zakariya I, Úbeda A, Parra M, Macías D, Tomás JI, Rezusta A, Rodríguez A, Gómez F, Martín-Mazuelos E, Cava Trem Study Group.
    Crit Care; 2016 May 16; 20(1):149. PubMed ID: 27181045
    [Abstract] [Full Text] [Related]

  • 13. Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis. A proteomic approach.
    Sáez-Rosón A, Sevilla MJ, Moragues MD.
    Int Microbiol; 2014 Mar 16; 17(1):21-9. PubMed ID: 25296443
    [Abstract] [Full Text] [Related]

  • 14. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
    Martínez-Jiménez MC, Muñoz P, Valerio M, Vena A, Guinea J, Bouza E.
    J Antimicrob Chemother; 2015 Nov 16; 70(11):3107-15. PubMed ID: 26311840
    [Abstract] [Full Text] [Related]

  • 15. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, Martín-Mazuelos E, Blanco A, Jerez V, Ballús J, Alvarez-Rocha L, Utande-Vázquez A, Fariñas O.
    Intensive Care Med; 2012 Aug 16; 38(8):1315-25. PubMed ID: 22752333
    [Abstract] [Full Text] [Related]

  • 16. Anti-Candidaalbicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans.
    Carrano G, Paulone S, Lainz L, Sevilla MJ, Blasi E, Moragues MD.
    Rev Iberoam Micol; 2019 Aug 16; 36(1):9-16. PubMed ID: 30686747
    [Abstract] [Full Text] [Related]

  • 17. Detection of antibodies to Candida albicans germ tubes during experimental infections by different Candida species.
    Bikandi J, San Millán R, Regúlez P, Moragues MD, Quindós G, Pontón J.
    Clin Diagn Lab Immunol; 1998 May 16; 5(3):369-74. PubMed ID: 9605993
    [Abstract] [Full Text] [Related]

  • 18. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
    Muñoz P, Vena A, Machado M, Gioia F, Martínez-Jiménez MC, Gómez E, Origüen J, Orellana MÁ, López-Medrano F, Fernández-Ruiz M, Merino P, González-Romo F, Frías I, Pérez-Granda MJ, Aguado JM, Fortún J, Bouza E, T2MadRid study group.
    J Antimicrob Chemother; 2018 Mar 01; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
    [Abstract] [Full Text] [Related]

  • 19. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia.
    Martínez-Jiménez MC, Muñoz P, Guinea J, Valerio M, Alonso R, Escribano P, Bouza E.
    Med Mycol; 2014 Apr 01; 52(3):270-5. PubMed ID: 24662248
    [Abstract] [Full Text] [Related]

  • 20. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses.
    Pitarch A, Jiménez A, Nombela C, Gil C.
    Mol Cell Proteomics; 2006 Jan 01; 5(1):79-96. PubMed ID: 16195222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.